Clin Exp Immunol 2008 154: 270–284.īrehm MA, Cuthbert A, Yang C, Miller DM, DiIorio P, Laning J et al. ![]() Non-obese diabetic-recombination activating gene-1 (NOD-Rag1 null) interleukin (IL)-2 receptor common gamma chain (IL2rγ null) null mice: a radioresistant model for human lymphohaematopoietic engraftment. Pearson T, Shultz LD, Miller D, King M, Laning J, Fodor W et al. Development of a human adaptive immune system in cord blood cell-transplanted mice. Traggiai E, Chicha L, Mazzucchelli L, Bronz L, Piffaretti JC, Lanzavecchia A et al. Enhanced human cell engraftment in mice deficient in RAG2 and the common cytokine receptor gamma chain. Goldman JP, Blundell MP, Lopes L, Kinnon C, Di Santo JP, Thrasher AJ. Human lymphoid and myeloid cell development in NOD/LtSz- scid IL2Rγ null mice engrafted with mobilized human hemopoietic stem cells. Shultz LD, Lyons BL, Burzenski LM, Gott B, Chen X, Chaleff S et al. NOD/SCID/γc null mouse: an excellent recipient mouse model for engraftment of human cells. Ito M, Hiramatsu H, Kobayashi K, Suzue K, Kawahata M, Hioki K et al. NOD/LtSz-Rag1 nullPfp null mice: a new model system with increased levels of human peripheral leukocyte and hematopoietic stem-cell engraftment. Shultz LD, Banuelos S, Lyons B, Samuels R, Burzenski L, Gott B et al. Enhanced human CD4 + T cell engraftment in β2-microglobulin-deficient NOD- scid mice. LeukeSuppl 3, 109–112.Ĭhristianson SW, Greiner DL, Hesselton RA, Leif JH, Wagar EJ, Schweitzer IB et al. High levels of viremia in hu-PBL-NOD- scid mice with HIV-1 infection. Koyanagi Y, Tanaka Y, Tanaka R, Misawa N, Kawano Y, Tanaka T et al. Multiple defects in innate and adaptive immunologic function in NOD/LtSz- scid mice. Shultz LD, Schweitzer PA, Christianson SW, Gott B, Schweitzer IB, Tennent B et al. A severe combined immunodeficiency mutation in the mouse. Mouse News Lett 1962 27: 31.īosma GC, Custer RP, Bosma MJ. Mouse models with human immunity and their application in biomedical research. Experimental models to study development and function of the human immune system in vivo. NOD/Shi- scid IL2rγ null (NOG) mice more appropriate for humanized mouse models. Humanized mice in translational biomedical research. Various human disease mouse models using these humanized mice are summarized. In this review, we describe the current knowledge of human hematopoietic cells developed in these mice. These mice were generated by genetically introducing human cytokine genes into NOD/SCID/γc null and Rag2 nullγc null mice. More recently, a new series of immunodeficient mice compensates for these disadvantages. However, human hematopoietic cells developed from HSCs are not always phenotypically and functionally identical to those in humans. These humanized mice facilitate the analysis of human hematology and immunology in vivo. These strains show not only a high rate of human cell engraftment, but also generate well-differentiated multilineage human hematopoietic cells after human hematopoietic stem cell (HSC) transplantation. Since the early 2000s, a series of immunodeficient mice appropriate for generating humanized mice has been successively developed by introducing the IL-2Rγ null gene (e.g., NOD/SCID/γc null and Rag2 nullγc null mice). Highly immunodeficient mice, which do not reject xenografts and support cell and tissue differentiation and growth, are indispensable for generating additional appropriate models. ![]() Humanized mouse models that have received human cells or tissue transplants are extremely useful in basic and applied human disease research.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |